The prevalence of pulmonary hypertension and the related factors in hemodialysis patients

A. Sharifpour, O. Sedighi, S. Golshani, F. Mahjoob (Sari, Islamic Republic Of Iran)

Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Session: Respiratory manifestations of systemic disease: a holistic approach
Session type: Thematic Poster Session
Number: 581
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sharifpour, O. Sedighi, S. Golshani, F. Mahjoob (Sari, Islamic Republic Of Iran). The prevalence of pulmonary hypertension and the related factors in hemodialysis patients. Eur Respir J 2012; 40: Suppl. 56, 581

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Prevalence of pulmonary hypertension in patients undergo hemodialysis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012


Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011


The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010


Prevalence of pulmonary hypertension in patients after splenectomy
Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease
Year: 2008


Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020


Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: ERJ Open Res, 6 (4) 00299-2020; 10.1183/23120541.00299-2020
Year: 2020



Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012



Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009



Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension
Source: ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018
Year: 2018



Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019

Age, risk and outcomes in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018
Year: 2018



Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Year: 2018



Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017
Year: 2018



Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 549-555
Year: 2010